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Abstract 
Hepatic Ischemia and Reperfusion Injury (IRI) is a major cause of liver damage during liver 
surgery and transplantation. Ischemic preconditioning and postconditioning are strategies that 
can reduce IRI. In this study, different combined types of pre- and postconditioning proce-
dures were tested in a murine warm hepatic IRI model to evaluate their protective effects. 
Proanthocyanidins derived from grape seed was used before ischemia process as pharma-
cological preconditioning to combine with technical preconditioning and postconditioning. 
Three  pathways  related  to  IRI,  including  reactive  oxygen  species  (ROS)  generation, 
pro-inflammatory cytokines release and hypoxia responses were examined in hepatic IRI 
model. Individual and combined pre- and postconditioning protocols significantly reduce liver 
injury by decreasing the liver ROS and cytokine levels, as well as enhancing the hypoxia tol-
erance response. Our data also suggested that in addition to individual preconditioning or 
postconditioning,  the  combination  of  these  two  treatments  could  reduce  liver  ische-
mia/reperfusion injury more effectively by increasing the activity of ROS scavengers and an-
tioxidants. The utilization of grape seed proanthocyanidins (GSP) could improve the oxida-
tion resistance in combined pre- and postconditioning groups. The combined protocol also 
further increased the liver HIF-1 alpha protein level, but had no effect on pro-inflammatory 
cytokines release compared to solo treatment. 
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INTRODUCTION 
Hepatic Ischemia and Reperfusion Injury (IRI), 
an  exogenous  antigen-independent  inflammatory 
event, is a major complication in liver surgery, par-
ticularly in liver transplantation and hepatic resection 
[1, 2]. IRI has both immediate and long-term effects on 
the allograft, causing up acute rejection and chronic 
allograft  dysfunction,  which  in  turn  significantly 
contributes to the morbidity and mortality after oper-
ation [3].  
 Increasing  evidences  have  shown  that  both 
pro-inflammatory cytokines and the reactive oxygen 
species  (ROS)  are  key  mediators  of  liver  IRI  [4,  5]. 
Shortly  after  the  hepatic  ischemia  and  reperfusion 
injury (1-6 hours), the Kupffer cells are activated and 
release  the  pro-inflammatory  cytokines,  such  as  tu-
mor necrosis factor alpha (TNF α) and interleukin-1 
beta  (IL-1β).  These  cytokines  have  dual  role:  over 
range expression of TNFα and IL-1β can induce more 
production  of  cytokines  and  granulocyte  colo-
ny-stimulating  factor,  which  enhance  Kupffer  cells 
activation and promote neutrophil infiltration in mi-
crocirculation  of  liver  [6,  7],  then  aggravate  hepatic 
sterile inflammation  after ischemia and reperfusion. 
On the other hand, TNFα and IL-1 are indispensable 
for liver regeneration [8].  
 At the same time, Kupffer cells and hepatocytes 
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also generate ROS, which leading to direct damage on 
endothelial cells (ECs) and hepatocytes. Due to their 
important role, ROS levels have to be tightly regulat-
ed through different pathways [9, 10]. The major regu-
lators  are  ROS  scavengers  that  include  superoxide 
dismutases  (SOD),  catalase  (CAT),  and  glutathione 
peroxidase (GSH-Px). These ROS scavengers are re-
sponsible  for  reducing  ROS  inside  the  tissues.  An-
other kind of oxidative stress regulation is mediated 
by nitric oxide (NO), which is created by endothelial 
nitric  oxide  synthases  (eNOS)  and  inducible  nitric 
oxide synthases (iNOS) in liver. Nitric oxide can reg-
ulate  endothelial  function  and  its  level  can  affect 
blood flow of an organ [11]. The reduction of NO level 
is always associated with IRI. 
 The whole process of ischemia and reperfusion 
(I/R) is complicated and the production and release of 
ROS appears to directly result in hepatocellular inju-
ry; at the same time, inflammatory disorder mediated 
by recruited neutrophils can also result in hepatocel-
lular injury. On the other hand, cells can spontane-
ously  respond  to  injury  by  activating  defensive 
mechanisms  of  themselves.  Among  them,  hypoxia 
inducible factor-1 alpha (HIF-1α) is a very important 
nuclear factor act as the oxygen  sensor. It plays an 
important role in the pathogenesis and development 
of  various  hypoxic/ischemic  diseases  [12,  13].  It  was 
reported that ischemic preconditioning could attenu-
ate  ischemic  injury  and  increase  the  expression  of 
HIF-1α  which  involved  in  oxygen  homeostasis  re-
sponded to diminished oxygen tension  [5, 14]. HIF-1α 
can also regulate the expression of the genes such as 
heme  oxygenase-1  (HO-1)  and  vascular  endothelial 
growth factor (VEGF)  [15-20], which can effect on en-
dothelial cells (ECs) proliferation, migration, and cell 
organization  during  recovery  phases  after  hepatic 
microvascular dysfunction by promoting the secretion 
of growth and survival factors. The stability of HIF-1α 
protein is tightly regulated by the oxygen level of the 
tissue.  The  degradation  of  HIF-1α  is  mediated  by 
proline hydroxylases (PHDs), which can catalyse the 
hydroxylation  of  specific  proline  residues  in  the 
HIF-1α  subunits.  The  activation  of  PHDs  is  oxy-
gen-dependent.  
 Although  the  molecular  mechanisms  underly-
ing  IRI  remain  to  be  clearly  elucidated,  during  the 
past  several  years,  many  investigations  have  their 
focus on the intervention of hepatic IRI [21-23]. Ischemic 
preconditioning  (IpreC),  defined  as  brief  periods  of 
ischemia and reperfusion before sustained ischemia, 
is a promising approach to minimize hepatic IRI in 
animals and humans  [1, 2]. Direct mechanical precon-
ditioning in target organ has the benefit of reducing 
ischemia-reperfusion  injury  (IRI),  and  resulting  in 
increased tolerance toward organ hypoxia. However, 
its main disadvantage is trauma to major vessels and 
stress to the target organ [20, 24]. Remote ischemia pre-
conditioning (RIPC) is a recent observation in which 
brief ischemia of one organ has been shown to confer 
protection on distant organs without direct stress or 
trauma to blood vessels of the organ. RIPC was re-
ported for reducing myocardial and renal injury [25- 27]. 
Furthermore, recent studies have proved that several 
brief cycles of ischemia and reperfusion at the onset of 
sustained reperfusion after ischemia, termed ischemic 
postconditioning (IpostC), provided effective cardio-
protection on IRI. But most of these studies were fo-
cused on hearts and little was known about whether 
IpostC  offered  protections  on  hepatic  IRI  and  the 
mechanism  [28-31].  Proanthocyanidins,  mainly  pre-
senting in the seeds of grapes, has been reported to 
possess  a  broad  spectrum  of  biological,  pharmaco-
logical and therapeutic activities against free radicals 
and oxidative stress. Vitro studies reported that pro-
anthocyanidins  were  potent  scavengers  of  peroxyl 
and  hydroxyl  radicals  that  were  generated  in  the 
reperfusion  myocardium  after  ischemia.  However, 
fewer  reports  demonstrated  their  effects  on  hepatic 
ischemic and reperfusion injury [32, 33].  
In  this  paper,  the  protective  effects  of  IpreC, 
RIPC (we executed remote ischemia preconditioning 
on hind limbs of mice) and IpostC were evaluated on 
the warm IRI model of mouse liver. The results show 
that all these three strategies were effective on pro-
tecting liver against ischemia and reperfusion injuries, 
and  providing  the  preservation  of  hepatic  function. 
Combined IpreC with IpostC could offer additional 
protection  over  the  solo  treatment.  In  addition,  the 
underlying mechanisms were examined by monitor-
ing the production of pro-inflammatory cytokines and 
ROS. We also observed the level of HIF-1α in the IRI 
liver tissue. The protective effects of individual IpreC 
and  IpostC  against  hepatic  IRI  was  related  with  its 
ability to reduce tissue oxidative stress level by mod-
ulating the activities of SOD, GSH-PX, CAT and NOS. 
Pre-  and  Post-conditioning  procedures  could  also 
decrease  the  cellular  injuries  and  promote  cell  sur-
vival  through  suppressing  cytokine  production. 
Up-regulation of the HIF-1α and VEGF protein level 
was also evident after IpreC and IpostC treatment.  
Our studies also suggested that the synergistic 
protection  by  combined  pre-  and  post  conditioning 
was contributed by increased CAT and GSH-Px ac-
tivities,  as  well  as  enhanced  hypoxia  self-defensive 
response.  However,  combined  IpreC  and  IpostC 
failed to further reduce cytokines release compared to 
individual  treatment.  The  utilization  of  grape  seed 
proanthocyanidins in our research showed that GSP Int. J. Biol. Sci. 2012, 8 
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could  further  improve  the  oxidation  resistance  in 
combined pre- and postconditioning groups, and its 
implementation was more convenient particularly in 
combined  remote  preconditioning  and  postcondi-
tioning  group.  All  these  results  provided  experi-
mental evidences to evaluate the protective effects of 
IpostC/IpreC strategies against hepatic IRI in details 
and may guide future research on anti-IRI. Further-
more, the combination of GSP, remote ischemic pre-
conditioning and postconditioning strategy was more 
humane  and  relatively  easier  to  be  operated,  espe-
cially during the warm liver transplantation: the do-
nor  willing  to  accept  the  nondestructive  precondi-
tioning  and  postconditioning  is  convenient  to  carry 
out before reopen blood supply on graft in the recep-
tor, this combination protocol  might have huge po-
tential to be used in clinical surgery.  
MATERIALS AND METHODS 
Mice  
Male  inbred  wild-type  (WT)  C57BL/6  mice 
weighing  25-30gm  were  used.  The  animals  were 
housed  in  China  medical  university  animal  facility 
under specific pathogen-free conditions and received 
humane  care  according  to  National  Institutes  of 
Health guidelines. The mice received GSP precondi-
tioning  were  injected  GSP  intraperitoneally 
20mg/kg/day for three weeks before using, while the 
mice in control group were injected the same volume 
normal saline.  
Mouse Hepatic IRI Model 
An established mouse warm hepatic IRI model 
[30]  was  used  with  modification.  Briefly,  mice  were 
injected with heparin (100U/kg), and an atraumatic 
clip was used to interrupt the arterial and portal ve-
nous blood supply to the cephalad lobes of the liver. 
After 30 minutes of ischemia, the clip was removed, 
initiating  hepatic  reperfusion.  Mice  were  sacrificed 
after 1h to analyze the acute phase of liver IRI [31]. GSP 
(purity>95%)  provided  by  Tianjin  Jianfeng  Natural 
Product R&D, Co. Ltd and was diluted by distilled 
water before using.  
Groupings were listed as in Fig. 1A and Fig. 2A. 
Hepatocellular Injury Assay 
Aspartase  aminotransferase  (AST)  and  alanine 
aminotransferase (ALT) in serum were used as indi-
cators  of  hepatocyte  function.  Blood  samples  were 
centrifuged  immediately  at  8000  ×  g,  4°C  for  10 
minutes. Serum enzyme levels were measured with a 
Bayer 1650 automatic biochemical analyzer. 
Detection of the total antioxidative capacity 
and the activities of antioxidative enzymes in 
hepatocytes 
Tissue homogenate was made in PBS buffer and 
centrifuged at 1800× g 10min at 4°C to precipitate the 
insoluble material. The supernatant were used for the 
followed  assay.  The  total  antioxidative  capacity 
(T-AOC), malondialdehyde (MDA) and the activity of 
superoxide  dismutase  (SOD),  catalase  (CAT),  gluta-
thione  peroxidase  (GSH-PX),  Nitric  Oxide  Synthase 
(NOS)  were  measured  by  a  commercial  testing  kit 
(NanJing  JianCheng  Bioengineering  Institute)  ac-
cording to the manual.  
RNA extraction and Quantitative Real-Time 
PCR 
Total  RNA  was  isolated  from  mouse  liver  by 
RNeasy kit (Qiagen) according to the manufacturer's 
instructions.  cDNA  was  synthesis  as  suggested  by 
TaKaRa RNA PCR Kit (AMV) Ver3.0. Real-Time PCR 
was performed using ABI7300 system with the Fer-
mentas SYBR Green PCR pre mix. Primers are listed 
below: 
TNF-α:  5’GTGGGTGAGGAGCACGTAGT3’; 
and 5’CCCCAAAGGGATGAGAAGTT3’ 
IL-1:  5’CCTACCTTTGTTCCGCACAT3’;  and 
5’AAGTGTGTCATCGTGGTGGA3’  
HIF-1α:  5’CTGCCACTGCCACCACAACT3’; 
and 5’CAGGAAAGAGAGTCATAGAA3’  
PHD: 5’CCAGCACCTC GGGGTCTGCC3’;  and 
5’GACTCGTCCC TGTCCCACCT3’ 
VEGF:  5’GTCGGGTGGGAGTTATGG3’;    and 
5’GACGAGGTTTGAGGAAGG3’  
ELISA and Immunoblotting 
Livers  were  removed  from  the  mice,  washed 
with PBS, and weighed. Livers were homogenized in 
cold PBS buffer and centrifuged at 1800× g 10mins at 
4°C. The supernatant were used in the ELISA assay. 
TNFα  and  IL-1  levels  were  determined  by  the 
EBIOSCIENCE Mouse ELISA Ready-SET-Go kit. For 
immunoblotting assay, mouse liver lysate was made 
in RIPA buffer and separated on SDS-page gel. The 
HIF-1 α, PHD,  VEGF and GAPDH antibodies were 
bought from Abcam Ltd (USA).  
Statistical Analysis 
Statistical  analyses  were  performed  by  SPSS 
programs. All data are expressed as means ± standard 
deviation. Differences between experimental groups 
were  analyzed  with  an  unpaired  2-tailed  Student  t 
test. All differences were considered statistically sig-
nificant at a P value <0.05. Int. J. Biol. Sci. 2012, 8 
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RESULTS 
Ischemic preconditioning and postconditioning 
reduce hepatic ischemia and reperfusion injury 
 In the first set of experiments, ALT and AST ac-
tivities were used as markers to evaluate the effects of 
various  ischemic  postconditioning  strategies  against 
hepatic ischemia and reperfusion injury. Compared to 
control group, the plasma activities of ALT and AST 
significantly  decreased  in  IpostC-2  and  IpostC-3 
groups (P<0.05), decreased more obviously in group 
IpostC-2,  as  shown  in  Figure  1B.  No  significant  al-
ternations of the activities of ALT and AST in plasma 
were found in IpostC-1 group. Due to the significant 
protection function of IpostC-2, IpostC-2 was used in 
the combined Pre-, remote preconditioning and GSP 
ip procedure in the followed experiments. 
Combinations of the preconditioning and 
postditioning procedures provide synergistic 
protection against the ischemic reperfusion 
injury 
 Our  hypothesis  was  that  combinations  of  the 
preconditioning  and  postconditoning  procedures 
would show more effective protection effects against 
hepatic ischemia and reperfusion injury than the in-
dividual  treatment.  To  test  this  hypothesis,  we  de-
signed  different  experimental  protocols  and  meas-
ured the plasma activities of ALT and AST in serum 
as shown in Figure 2A. Indeed, the activities of these 
two enzymes were significantly decreased in IpreC-H, 
IpreC-L,  IpostC-2,  IpreC-H/  IpostC-2  and  IpreC-L/ 
IpostC-2 groups (P<0.05) compared to control group 
(Figure  2B).  Remote  ischemia  preconditioning 
(IpreC-L) showed similar protective affect against IRI 
as  direct  ischemia  preconditioning  (IpreC-H).  More 
importantly,  compared  to  IpreC-H  and  IpreC-L 
groups, the activities of ALT and AST in IpreC-H/ 
IpostC-2  and  IpreC-L/  IpostC-2  groups  decreased 
more obviously (P<0.05). Hence, the combinations of 
the pre- and post conditioning produce better hepatic 
protection  than  individual  treatments.  Besides,  the 
utilization  of  GSP  in  our  studies  showed  that  GSP 
could further reduce the activities of ALT and AST in 
combined  preconditioning  and  postconditioning 
groups (P<0.05) compared to IpreC-H/ IpostC-2 and 
IpreC-L/ IpostC-2 groups (Figure 2C).  
 
 
Figure 1. Effects of ischemic postconditioning on the activities of ALT and AST in serum. Experimental protocols of the IRI (control 
group) and the ischemic conditioning (pre-, postconditioning groups). IRI: 30 minutes of ischemia followed with 1 hour reperfusion. 
Dotted areas represent the periods of ischemia; Black areas represent the periods of perfusion. IpostC procedure: 10, 30, 60 seconds 
of reperfusion followed by 10, 30, 60 seconds of reocclusion for three times at the onset of reperfusion. (B) ALT and A ST activities in 
mice serum were measured at 1 hour after perfusion. (mean ±s, n=7) Activities of these two enzymes are significantly lower in serum in 
IpostC-2 and IpostC-3 groups. (* indicate P<0.05 when compared with control group ) Int. J. Biol. Sci. 2012, 8 
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Figure 2. Effects of Ischemic conditioning in solo or combined protocols and GSP on the activities of ALT and AST in serum. (A) 
Experimental protocols  of  individual  or  combined  pre-  and post-  conditioning  protocols.  Direct  mechanical  preconditioning 
(IpreC-H): The portal triad was occluded for 5 minutes followed by reperfusion for 5 minutes, repeated three times before hepatic 
ischemic, reperfusion procedures. Remote ischemia preconditioning of hind limb (IpreC-L): The hind limbs of the mice were 
tightly binding by hemostasis clips for 10 minutes followed by reperfusion for 10 minutes, repeated three times before hepatic ischemic, 
reperfusion procedures. Dotted areas represent the periods of ischemia; Black areas represent the periods of perfusion. GSP pre-
conditioning: The mice received GSP preconditioning were injected GSP intraperitoneally 20mg/kg/per day for three weeks before 
using. (B) ALT and AST activities in mice serum were measured at 1 hour after perfusion. (mean ±s, n=7). (* indicate P<0.05 when 
compared with control group;  ﹟indicate P<0.05 when compared with IpostC-2 group). GSP could further reduce the activities of ALT 
and AST in combined remote preconditioning and postconditioning groups. (mean ±s, n=7). (* indicate P<0.05 when compared with 
control group;  ﹟indicate P<0.05 when compared with IpostC-2 group; ▲indicate P<0.05 when compared with IpreC-H/ IpostC-2 and 
IpreC-L/ IpostC-2). Int. J. Biol. Sci. 2012, 8 
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Figure 3. Cytokines level in mouse serum after IpostC, IpreC treatment. TNF-α and IL-1β level were measured in mice serum. (mean ±s, 
n=7). (* indicate P<0.05 when compared with control group;  ﹟indicate P<0.05 when compared with IpostC-2 group). (B) TNF-α and 
IL-1β mRNA abundance in serum were quantified by RT-PCR. Results obtained with pre-, post- conditioning groups were normalized to 
results obtained with control group, which were given a value of 1. (mean ±s, n=7). (*  indicate P<0.05 when compared with control group;  
﹟indicate P<0.05 when compared with IpostC-2 group). 
 
TNF-α and Interleukin-1 (IL-1β) levels reduced 
in the pre- and post- conditioning groups 
 Pro-inflammatory cytokines, including cytokine 
TNFα  and  IL-1β,  are  important  mediators  of  the 
apoptotic  pathway  following  reperfusion  injury. 
Compared  to  control  samples,  the  concentration  of 
TNF-α  and  IL-1β  in  serum  were  dramatically  de-
creased  in  IpreC-H,  IpreC-L,  IpostC-2,  IpreC-H/ 
IpostC-2  and  IpreC-L/  IpostC-2  groups  (P<0.05) 
(Figure  3A).  And  the  pro-inflammatory  cytokines 
reduction  was  caused  by  the  decreased  mRNA  ex-
pression as shown in Figure 3B. Please note that the 
combined pre- and postconditioning failed to further 
reduce the TNFα and IL-1β level in the mouse serum 
over individual procedure.  
Response of antioxidative pathways in the pre- 
and post conditioning process 
 Another important factor causing ischemia and 
reperfusion injury are reactive oxygen species (ROS) 
mediated  cell  apoptosis.  To  investigate  the  role  of 
ROS in IR injury, we first measured the total antioxi-
dative  capacity  (T-AOC)  and  malondialdehyde 
(MDA) level that indicate the overall level of the tis-
sue oxidative stress. As shown in  Figure 4A, either 
individual or combinations of IpostC, IpreC protocol 
could decrease the oxidative stress level indicated by 
reduced MDA content and elevated T-AOC content. 
To  quantify  the  contribution  of  different  ROS  scav-
engers, the activity of  superoxide dismutase (SOD), 
catalase  (CAT),  glutathione  peroxidase  (GSH-PX), 
total  nitric  oxide  synthase  (NOS)  and  iNOS  were 
measured in the mouse serum 1 hour after perfusion. 
The  activities  of  all  these  enzymes  elevated  in 
IpreC-H, IpreC-L, IpostC-2, IpreC-H/ IpostC-2 and 
IpreC-L/  IpostC-2  groups  at  1h  after  reperfusion 
(P<0.05)  (Figure  4B  and  C).  Interestingly,  only  the 
activities of GSH-PX and CAT showed more dramatic 
elevation in IpreC-H/ IpostC-2 and IpreC-L/ IpostC-2 Int. J. Biol. Sci. 2012, 8 
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groups than those in the individual IPreC and IpostC 
groups. But in the GSP combined IpreC-H/ IpostC-2 
and IpreC-L/ IpostC-2 groups, the activity of all these 
ROS  scavengers  and  antioxidants  were  increased 
(P<0.05)  compared  to  IpreC-H/  IpostC-2  and 
IpreC-L/ IpostC-2 groups (Figure 4D).  
Effect of ischemic postconditioning on the 
tissue hypoxia response 
In addition to the cytokine and ROS level, hy-
poxia  was  reported  as  an  important  environmental 
alteration in the process of liver IR injury. Adaptation 
to hypoxia are mediated by hypoxia-inducible factor 
1(HIF-1),  which  is  a  master  transcriptional  factors 
activated by low oxygen tension. HIF-1α and its sig-
naling pathway component PHD level were analyzed 
by immunoblotting and Real Time PCR. As shown in 
Figure 5A, the expression of HIF-1α and VEGF were 
clearly  increased  in  IpreC-H,  IpreC-L,  IpostC-2, 
IpreC-H/  IpostC-2  and  IpreC-L/  IpostC-2  groups 
when compared with the control group. The expres-
sion  of  PHD  protein  only  showed  mild  change, 
probably  because  the  activity  of  PHD  protein  was 
biochemically  regulated  by  the  tissue  oxygen  level. 
Compared to IpreC-H and IpreC-L groups, combined 
IpreC and IpostC could further increase (P<0.05) the 
expression of HIF-1α and VEGF, particularly in the 
GSP  combined  IpreC-H/  IpostC-2  and  IpreC-L/ 
IpostC-2 groups (P<0.05) (Figure 5B).  
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Figure 4. Effects of Ischemic preconditioning, postcondioning protocols and GSP on hepatic oxidative stress. Total antioxidative capacity 
(T-AOC) and the malondialdehyde (MDA) contents in mouse liver. (mean ±s, n=7). (* indicate P<0.05 when compared with control 
group;  ﹟indicate P<0.05 when compared with IpostC-2 group). SOD, CAT and GSH-PX enzymatic activities and (C) T-NOS and iNOS 
activities in mouse liver. (mean ±s, n=7). (* indicate P<0.05 when compared with control group;  ﹟indicate P<0.05 when compared with 
IpostC-2 group). (C) Effect of GSP on the activities of ROS scavengers and antioxidants. (mean ±s, n=7). (* indicate P<0.05 when 
compared with control group;  ﹟indicate P<0.05 when compared with IpostC-2 group; ▲indicate P<0.05 when compared with IpreC-H/ 
IpostC-2 and IpreC-L/ IpostC-2).) Int. J. Biol. Sci. 2012, 8 
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Figure 5. Effect of pre- and postconditioning on the expression level of HIF-1 alpha, PHD and VEGF. Whole cell extracts made from 
mouse liver were separated on SDS- page gel. HIF-1 α, PHD, VEGF and GAPDH protein level were determined by immunblotting with the 
specific antibodies against the proteins listed on the right. GAPDH was used as a loading control. Effect of GSP on the expression level of 
HIF-1 alpha, PHD and VEGF. (mean ±s, n=7). HIF-1 α, PHD, VEGF and GAPDH mRNA level were determined by Real-Time PCR. (* 
indicate P<0.05 when compared with control group;  ﹟indicate P<0.05 when compared with IpostC-2 group; ▲indicate P<0.05 when 
compared with IpreC-H/ IpostC-2 and IpreC-L/ IpostC-2). Int. J. Biol. Sci. 2012, 8 
 
 
http://www.biolsci.org 
716 
DISSCUSSION  
Evaluation of the protective effects of pre- and 
postconditioning against the IRI 
Numerous studies have investigated the under-
lying mechanisms of ischemia and reperfusion injury 
with  the  goal  of  finding  therapeutic  approaches  to 
enhance  ischemia  tolerance  [2-11].  Among  them,  is-
chemic  conditioning  (preconditioning,  postcondi-
tioning  and  remote  conditioning)  was  widely  used 
and  these  strategies  could  provide  tissue-protective 
effects  after  ischemia  and  reperfusion  injury.  (a)  Is-
chemia preconditioning (IpreC), this strategy has re-
ceived  wide  range  of  research  and  made  great 
achievements because of its significant protective ef-
fects on hepatic ischemia reperfusion injury by stim-
ulating endogenous protective mechanisms. Howev-
er, IpreC application time is hard to control (hard to 
implementation  before  unpredictable  long  time  of 
ischemia). (b) Remote organ ischemic preconditioning 
(RIPC): RIPC is brief ischemia and reperfusion of one 
organ to protect other distant organs from sustained 
IRI  without  direct  stress  to  the  organ  which  can 
overcome some  of  the limitations  of the direct pre-
conditioning. RIPC on limb, gut, mesenteric, or kid-
ney  can  reduce  myocardial  infarct  size  in  animal 
models. In humans, RIPC on skeletal can be used for 
protecting  heart  from  IRI.  (c)  Ischemic  postcondi-
tioning  (IpostC):  Unlike  IpreC,  IpostC  applies  the 
brief episodes of ischemia at the onset of reperfusion 
following a prolonged ischemia[36]. Since IpostC can 
be easily applied with precisely controlled timing,  this 
approach appears to have greater potential for clinical 
application. However, most of the current studies are 
concentrated on the IRI of heart due to the remarkable 
success of postconditioning, and it remains to be de-
termined whether IpostC can provide similar effective 
protection on hepatic IRI compared to IpreC.  
We are the first to evaluate these strategies side 
by side in a mouse model using ALT and AST activi-
ties as biomarkers. In our study, hepatic IpostC were 
established  by  three  sets:  10,  30  and  60  seconds  of 
reperfusion followed by 10, 30 and 60 seconds of is-
chemia for three times at the onset of reperfusion. The 
results showed that 30 and 60 seconds IpostC could 
offer effective protection but the 30 seconds protocol 
could  provide  the  best  protection.  Our  study  also 
found  that  both  direct  ischemic  preconditioning 
(IpreC-H)  and  remote  ischemic  preconditioning 
(IpreC-L) were effective interventions to hepatic IRI 
and the latter one was more convenient for applica-
tion without the direct damage to blood vessels of the 
IRI liver. Significantly, IpostC could offer almost the 
same level of protection as IpreC on hepatic IRI and 
might be easier for doctors to control the surgery time.  
 It  was  the  first  time  that  the  combined  RIPC 
(IpreC-L) and IpostC procedures was tested on mice 
hepatic IRI model while most of studies of this field 
were  focused  on  solo  treatment  on  ischemia  and 
reperfusion  organs.  Our  data  suggested  that  com-
pared  with  the  individual  treatment,  the  combined 
IpreC  and  IpostC  could  offer  additional  protection. 
Because the combination of IpreC-L and IpostC-2 was 
relatively easier to be operated, they could have huge 
potential to be used in a clinical surgery. However, 
the significance of our studies in human is still need to 
be determined in future.  
 
The mechanisms by which that pre- and 
postconditioning decreasing the liver injury  
The mechanisms involved in IpreC and IpostC 
on hepatic IRI also had been investigated in our study 
in  detail.  Our  results  suggested  that  the  protective 
effects of IpreC and IpostC against hepatic IRI were 
related with their roles in reducing the tissue oxida-
tive stress level [35, 36]. Both pre- and postconditioning 
could regulate the activities of  SOD,  GSH-PX,  NOS 
and CAT. Combined ischemic preconditioning with 
ischemic  postconditioning  could  offer  additive  pro-
tection by increase the GSH-PX and CAT activities. 
IpreC and IpostC could also decrease the cellular in-
juries and promote cell survival through suppressing 
cytokines  release.  But  combined  IpreC  and  IpostC 
could not further change the cytokines level. As re-
ported, IpreC and IpostC have similar physiological 
and  cellular  protection  mechanism:  they  have  the 
same  catalytic  substrate--  adenosine;  they  transport 
bioinformation through PI3K/Akt pathway; they can 
decrease cytokines release, etc [20]. All these suggested 
that  individual  application  IpreC  or  IpostC  might 
reach the limit of decreasing cytokines release in mice, 
then the  combinations of  pre- and postconditioning 
failed to further reduce the TNFα and IL-1β produc-
tion. Recent studies have hypothesized a role of TNFα 
and  IL-1β  in  liver  regeneration:  TNFα  and  IL-1  are 
indispensable for liver regeneration. So, our data con-
firmed that maintain the concentration of TNFα and 
IL-1 at certain level might help liver function recovery 
in  liver  regeneration  process.  The  expression  of 
HIF-1α  and  VEGF  were  increased  in  IpreC-H, 
IpreC-L, IpostC-2, IpreC-H/ IpostC-2 and IpreC-L/ 
IpostC-2 groups compared with control which would 
help illustrating the speed of cells regeneration and 
the recover status of hepatic function.  Int. J. Biol. Sci. 2012, 8 
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Grape seed proanthocyanidins (GSP) could 
further improve the oxidation resistance in 
combined pre- and postconditioning groups 
The therapeutic approaches to enhance ischemia 
tolerance,  besides  ischemic  conditioning,  covered 
metabolic  strategies,  therapeutic  gases  (NO,  H2S), 
nucleotide and microRNAs, et al. Some botanical ex-
tracts such as trans-resveratrol was recently used in 
hepatic  IRI  model  and  showed  its  benefits  on 
hepatocyte  protection  [37].  Grape  seed  proanthocya-
nidins has been reported to possess a broad spectrum 
of pharmacological and medicinal properties against 
oxidative  stress.  This  study  first  showed  that  GSP 
exerted an antioxidant effect on hepatic ischemic and 
reperfusion injury: GSP could improve the activities 
of ROS scavengers and oxidation resistance in com-
bined  pre-  and  postconditioning  groups.  More  im-
portant, the utilization of GSP was a well-accepted, 
noninvasive  way  to  be  operated  as  pharmacologic 
preconditioning  during  clinical  liver  transplantation 
and had minimal negative effects for patients to take 
without aggravating liver metabolic burden.  
In  summary,  the  comparation  between  these 
three  strategies  IpreC/RIPC/IpostC  was  associated 
with  their  comparable  protection  on  mouse  livers 
against warm IRI. Combined IpreC with IpostC could 
offer additive protection and the protocol of remote 
preconditioning  combined  with  IpostC-2  was  more 
convenient for clinical application. The utilization of 
grape seed proanthocyanidins (GSP) in our research 
showed that GSP could further improve the oxidation 
resistance  in  combined  pre-  and  postconditioning 
groups.  We  investigated  the  generation  of  reactive 
oxygen  species  and  pro-inflammatory  cytokines  in 
mice after hepatic ischemia reperfusion, which helped 
us find the best strategy suitable for decreasing the 
damage of warm IRI. And we also observed the al-
ternations of the hepatic tissues response to hypoxia: 
it described the hepatic own defensive condition and 
the mechanism of these strategies promoting the or-
gan fit for the oxygen-deficient environment. Further 
studies are necessary to determine other mechanisms 
involved in IpreC and IpostC, as well as the devel-
opment of novel drugs, which can mimic the function 
of pre- and postconditioning.  
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